This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
| Booker | Investec ups TP to 141p from 140p, Buy |
| British American Tobacco | Jefferies cuts TP to 3800p from 4000p, Buy |
| British American Tobacco | Credit Suisse cuts TP to 3700p from 3800p, outperform |
| CCH | JP Morgan cuts TP to 1860p from 1920p, overweight |
| Consort Medical | Investec downgrades to add from Buy; ups TP to 855p from 836p |
| CSR | JP Morgan ups TP to 550p from 530p, overweight |
| Debenhams | JP Morgan ups to overweight from neutral; TP to 118p from 95p |
| Domino Printing Sciences | Investec initiates with Hold; TP 600p |
| Drax | UBS ups TP to 710p from 685p, Buy |
| DS Smith | JP Morgan ups TP to 277p from 272p, overweight |
| ENRC | UBS downgrades to neutral from Buy; cuts TP to 230p from 285p |
| Greene King | Citigroup ups to Buy from neutral |
| Greene King | JP Morgan ups TP to 880p from 860p, overweight |
| Halma | JP Morgan ups TP to 510p fom 435p, neutral |
| Homeserve | JP Morgan downgrades to neutral from overweight |
| Provident Financial | RBC cuts TP to 1600p from 1700p, sector perform |
| The Paragon Group of Companies | RBC cuts TP to 350p from 370p, sector perform |
| Unilever | Goldman Sachs adds to conviction list; keeps Buy rating |
| Vodafone | Deutsche Bank ups to Buy |
| Wandisco | Panmure ups TP to 1132p from 1083p, Buy |
| Source: Reuters News, AlphaTerminal, Dow Jones Newswires | |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research